Evidence map›Paper›PMID 31979368›Full record

ReviewInternational journal of molecular sciences2020

The Endocannabinoid System: A Target for Cancer Treatment.

Chiara Laezza, Cristina Pagano, Giovanna Navarra, Olga Pastorino, Maria Chiara Proto, Donatella Fiore, Chiara Piscopo, Patrizia Gazzerro, Maurizio Bifulco

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed
14.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 145 citations in OpenAlex.

  1. Trial
  2. Selective CBPharmaceuticals (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Cannabinoid CBBritish journal of pharmacology · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Chiara LaezzaInstitute of Endocrinology and Experimental Oncology, IEOS CNR, 80131 Naples, Italy.
Cristina PaganoDepartment of Molecular Medicine and Medical Biotechnology, University of Naples "Federico II", 80131 Naples, Italy.
Giovanna NavarraDepartment of Molecular Medicine and Medical Biotechnology, University of Naples "Federico II", 80131 Naples, Italy.
Olga PastorinoDepartment of Molecular Medicine and Medical Biotechnology, University of Naples "Federico II", 80131 Naples, Italy.
Maria Chiara ProtoDepartment of Pharmacy, University of Salerno, 84084 Fisciano (SA), Italy.
Donatella FioreDepartment of Pharmacy, University of Salerno, 84084 Fisciano (SA), Italy.
Chiara PiscopoDepartment of Pharmacy, University of Salerno, 84084 Fisciano (SA), Italy.
Patrizia GazzerroDepartment of Pharmacy, University of Salerno, 84084 Fisciano (SA), Italy.
Maurizio BifulcoDepartment of Molecular Medicine and Medical Biotechnology, University of Naples "Federico II", 80131 Naples, Italy.
University of Naples Federico II · ITUniversity of Salerno · ITInstitute for Experimental Endocrinology and Oncology · IT

Funding

AIRC IG 18999
6 · The paper itself

Abstract

In recent years, the endocannabinoid system has received great interest as a potential therapeutic target in numerous pathological conditions. Cannabinoids have shown an anticancer potential by modulating several pathways involved in cell growth, differentiation, migration, and angiogenesis. However, the therapeutic efficacy of cannabinoids is limited to the treatment of chemotherapy-induced symptoms or cancer pain, but their use as anticancer drugs in chemotherapeutic protocols requires further investigation. In this paper, we reviewed the role of cannabinoids in the modulation of signaling mechanisms implicated in tumor progression.

Indexed as

AnimalsAntineoplastic AgentsCannabinoidsCell MovementCell ProliferationEndocannabinoidsFemaleGastrointestinal NeoplasmsHumansMaleNeoplasmsNeovascularization, PathologicReceptors, CannabinoidSignal TransductionAntineoplastic AgentsCannabinoidsEndocannabinoidsReceptors, Cannabinoidangiogenesiscancer stem cellCannabinoidsmetastasis

Identifiers

PMID31979368
PMCPMC7037210
OpenAlexW3001018370

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.